vs
Side-by-side financial comparison of Agilent Technologies (A) and Delek US Holdings, Inc. (DK). Click either name above to swap in a different company.
Delek US Holdings, Inc. is the larger business by last-quarter revenue ($2.6B vs $1.8B, roughly 1.5× Agilent Technologies). Agilent Technologies runs the higher net margin — 17.0% vs -7.7%, a 24.6% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs -4.9%). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs -10.8%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Delek US Holdings, Inc. is an oil refining, logistics and biofuels company founded in 2001 and headquartered in Brentwood, Tennessee.
A vs DK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $1.8B | $2.6B |
| Net Profit | $305.0M | $-201.3M |
| Gross Margin | 52.6% | -5.8% |
| Operating Margin | 19.6% | — |
| Net Margin | 17.0% | -7.7% |
| Revenue YoY | 7.0% | -4.9% |
| Net Profit YoY | -4.1% | — |
| EPS (diluted) | $1.07 | $-3.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | $2.6B | ||
| Q4 25 | $1.9B | $2.4B | ||
| Q3 25 | $1.7B | $2.9B | ||
| Q2 25 | $1.7B | $2.8B | ||
| Q1 25 | $1.7B | $2.6B | ||
| Q4 24 | $1.7B | $2.4B | ||
| Q3 24 | $1.6B | $3.0B | ||
| Q2 24 | $1.6B | $3.3B |
| Q1 26 | $305.0M | $-201.3M | ||
| Q4 25 | $434.0M | $78.3M | ||
| Q3 25 | $336.0M | $178.0M | ||
| Q2 25 | $215.0M | $-106.4M | ||
| Q1 25 | $318.0M | $-172.7M | ||
| Q4 24 | $351.0M | $-413.8M | ||
| Q3 24 | $282.0M | $-76.8M | ||
| Q2 24 | $308.0M | $-37.2M |
| Q1 26 | 52.6% | -5.8% | ||
| Q4 25 | 53.2% | 9.3% | ||
| Q3 25 | 51.1% | 13.8% | ||
| Q2 25 | 51.9% | 1.9% | ||
| Q1 25 | 53.5% | -2.4% | ||
| Q4 24 | 53.9% | -5.7% | ||
| Q3 24 | 54.2% | -0.7% | ||
| Q2 24 | 54.4% | 0.5% |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 6.8% | ||
| Q3 25 | 20.7% | 10.2% | ||
| Q2 25 | 18.0% | -1.2% | ||
| Q1 25 | 22.4% | -4.8% | ||
| Q4 24 | 24.0% | -17.0% | ||
| Q3 24 | 21.1% | -4.0% | ||
| Q2 24 | 23.1% | 0.1% |
| Q1 26 | 17.0% | -7.7% | ||
| Q4 25 | 23.3% | 3.2% | ||
| Q3 25 | 19.3% | 6.2% | ||
| Q2 25 | 12.9% | -3.8% | ||
| Q1 25 | 18.9% | -6.5% | ||
| Q4 24 | 20.6% | -17.4% | ||
| Q3 24 | 17.9% | -2.5% | ||
| Q2 24 | 19.6% | -1.1% |
| Q1 26 | $1.07 | $-3.34 | ||
| Q4 25 | $1.53 | $1.23 | ||
| Q3 25 | $1.18 | $2.93 | ||
| Q2 25 | $0.75 | $-1.76 | ||
| Q1 25 | $1.11 | $-2.78 | ||
| Q4 24 | $1.23 | $-6.48 | ||
| Q3 24 | $0.97 | $-1.20 | ||
| Q2 24 | $1.05 | $-0.58 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $624.1M |
| Total DebtLower is stronger | $3.0B | $3.2B |
| Stockholders' EquityBook value | $6.9B | $302.0M |
| Total Assets | $12.8B | $7.6B |
| Debt / EquityLower = less leverage | 0.44× | 10.54× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | $624.1M | ||
| Q4 25 | $1.8B | $625.8M | ||
| Q3 25 | $1.5B | $630.9M | ||
| Q2 25 | $1.5B | $615.5M | ||
| Q1 25 | $1.5B | $623.8M | ||
| Q4 24 | $1.3B | $735.6M | ||
| Q3 24 | $1.8B | $1.0B | ||
| Q2 24 | $1.7B | $657.9M |
| Q1 26 | $3.0B | $3.2B | ||
| Q4 25 | $3.0B | $3.2B | ||
| Q3 25 | $3.4B | $3.2B | ||
| Q2 25 | $3.3B | $3.1B | ||
| Q1 25 | $3.3B | $3.0B | ||
| Q4 24 | $3.3B | $2.8B | ||
| Q3 24 | $2.1B | $2.8B | ||
| Q2 24 | $2.1B | $2.5B |
| Q1 26 | $6.9B | $302.0M | ||
| Q4 25 | $6.7B | $547.3M | ||
| Q3 25 | $6.4B | $444.8M | ||
| Q2 25 | $6.1B | $294.9M | ||
| Q1 25 | $6.0B | $429.4M | ||
| Q4 24 | $5.9B | $575.2M | ||
| Q3 24 | $5.9B | $875.4M | ||
| Q2 24 | $6.2B | $982.8M |
| Q1 26 | $12.8B | $7.6B | ||
| Q4 25 | $12.7B | $6.8B | ||
| Q3 25 | $12.2B | $7.1B | ||
| Q2 25 | $12.2B | $7.1B | ||
| Q1 25 | $11.9B | $6.9B | ||
| Q4 24 | $11.8B | $6.7B | ||
| Q3 24 | $11.0B | $7.0B | ||
| Q2 24 | $10.9B | $6.9B |
| Q1 26 | 0.44× | 10.54× | ||
| Q4 25 | 0.45× | 5.91× | ||
| Q3 25 | 0.53× | 7.14× | ||
| Q2 25 | 0.55× | 10.51× | ||
| Q1 25 | 0.56× | 7.07× | ||
| Q4 24 | 0.57× | 4.81× | ||
| Q3 24 | 0.36× | 3.19× | ||
| Q2 24 | 0.34× | 2.50× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | — |
| Free Cash FlowOCF − Capex | $175.0M | — |
| FCF MarginFCF / Revenue | 9.7% | — |
| Capex IntensityCapex / Revenue | 5.2% | — |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $502.8M | ||
| Q3 25 | $362.0M | $44.0M | ||
| Q2 25 | $221.0M | $51.4M | ||
| Q1 25 | $431.0M | $-62.4M | ||
| Q4 24 | $481.0M | $-163.5M | ||
| Q3 24 | $452.0M | $-21.6M | ||
| Q2 24 | $333.0M | $-48.4M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $382.8M | ||
| Q3 25 | $259.0M | $-64.0M | ||
| Q2 25 | $107.0M | $-114.4M | ||
| Q1 25 | $334.0M | $-198.1M | ||
| Q4 24 | $388.0M | $-354.0M | ||
| Q3 24 | $360.0M | $-140.6M | ||
| Q2 24 | $230.0M | $-128.3M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 15.8% | ||
| Q3 25 | 14.9% | -2.2% | ||
| Q2 25 | 6.4% | -4.1% | ||
| Q1 25 | 19.9% | -7.5% | ||
| Q4 24 | 22.8% | -14.9% | ||
| Q3 24 | 22.8% | -4.6% | ||
| Q2 24 | 14.6% | -3.9% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 4.9% | ||
| Q3 25 | 5.9% | 3.7% | ||
| Q2 25 | 6.8% | 6.0% | ||
| Q1 25 | 5.8% | 5.1% | ||
| Q4 24 | 5.5% | 8.0% | ||
| Q3 24 | 5.8% | 3.9% | ||
| Q2 24 | 6.5% | 2.4% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 6.42× | ||
| Q3 25 | 1.08× | 0.25× | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.08× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
DK
Segment breakdown not available.